Financials in USD. Standardized financial statements.
A compact view of how Enfusion, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue? | $201.61M | $174.53M | $150.35M | $111.70M | $79.56M | $59.03M |
| Revenue Growth? | +15.5% | +16.1% | +34.6% | +40.4% | +34.8% | 0.0% |
| Cost of Revenue? | $64.87M | $57.64M | $47.10M | $31.84M | $21.36M | $16.96M |
| Gross Profit? | $136.74M | $116.89M | $103.25M | $79.86M | $58.21M | $42.07M |
| Gross Margin? | +67.8% | +67.0% | +68.7% | +71.5% | +73.2% | +71.3% |
| Operating Expenses? | $130.58M | $104.95M | $115.21M | $355.74M | $52.13M | $28.20M |
| Operating Income? | $6.16M | $11.95M | -$11.96M | -$275.88M | $6.07M | $13.87M |
| EBITDA? | $6.16M | $21.93M | -$5.36M | -$271.91M | $8.37M | $15.02M |
| Income Before Tax | $7.39M | $11.48M | -$12.19M | -$281.66M | $4.49M | $13.14M |
| Income Tax Expense | $4.57M | $2.23M | $1.07M | $579,000 | $433,000 | $486,000 |
| Net Income? | $2.82M | $6.03M | -$13.26M | -$282.24M | $4.06M | $12.66M |
| EPS? | $0.02 | $0.10 | $-0.16 | $-4.30 | $0.06 | $0.11 |
| Diluted EPS? | $0.01 | $0.07 | $-0.10 | $-4.30 | $0.06 | $0.11 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality